Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Pföhler, C; Ugurel, S.
Cutaneous reactions to molecular targeted therapies.
Hautarzt. 2008; 59(10):814-820
Doi: 10.1007/s00105-008-1540-0
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Ugurel-Becker Selma
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The use of molecular targeted therapies currently is on the rise in the treatment of severe diseases, particularly for malignant tumors. The targeted agents show a high specificity against one or more molecular target structures, hereby inhibiting or modifying signal transduction pathways connected to these targets, and thus strongly altering proliferation, activation and interaction of the targeted cells. These manipulations of highly specific signaling pathways are associated with again highly specific side effects, which often affect the skin. These cutaneous reactions present a new spectrum of adverse drug events to the dermatologist. We reviews the cutaneous reactions of molecular targeted agents used in the treatment of psoriasis (alefacept, efalizumab, etanercept, infliximab and adalimumab), as well as agents used in cancer therapy (imatinib, sorafenib, sunitinib, EGFR antagonists and CTLA-4-antagonists).
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents - adverse effects
- Dermatologic Agents - adverse effects
- Drug Delivery Systems - methods
- Drug Eruptions - etiology Drug Eruptions - prevention and control
- Humans -
- Immunologic Factors - adverse effects
- Molecular Probe Techniques -
- Find related publications in this database (Keywords)
- cutaneous reactions
- molecular targeted therapy
- psoriasis therapy
- cancer therapy
- cutaneous side effects